Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for edaravone in Relationship Comments (approximate match)

Showing 1 - 5 of 5 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

EDARAVONE

S798V6YJRP

Search for Structure

Status:

US Approved Rx (2017)

Source:

NDA209176

(2017)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209176

First approved in 2017

Source:

NDA209176

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209176

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

CHEMBL1689064: Hydroxyl Radical

Conditions:

Acute ischemic stroke

Amyotrophic lateral sclerosis

Edaravone is a free radical scavenger developed for the treatment of amyotrophic lateral sclerosis.

OAT-3

ZWJ2Y6JZWY

Subunit 1 (542) Similarity Search

Sequence Search

Subunit 1 (542) Similarity Search

Status:

Investigational

Source:

NCT03830736: Not Applicable Interventional Completed Postprandial Glucose Regulation

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03830736

Class:

PROTEIN

CYTOCHROME P450 1A2

VK4SQL11C0

Subunit 1 (514) Similarity Search

Sequence Search

Subunit 1 (514) Similarity Search

Status:

Investigational

Source:

NCT03333824: Phase 1 Interventional Completed Solid Tumours

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03333824

Class:

PROTEIN

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

76UB6O122H

Subunit 1 (655) Similarity Search Subunit 2 (655) Similarity Search Subunit 3 (655) Similarity Search Subunit 4 (655) Similarity Search

Sequence Search

Subunit 1 (655) Similarity Search Subunit 2 (655) Similarity Search Subunit 3 (655) Similarity Search Subunit 4 (655) Similarity Search

Status:

Other

Class:

PROTEIN

CYTOCHROME P450 2C9

L9DP834D1P

Subunit 1 (490) Similarity Search

Sequence Search

Subunit 1 (490) Similarity Search

Status:

Possibly Marketed Outside US

Source:

NCT02710747: Phase 4 Interventional Unknown status Heart Valve Disease

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02710747

Class:

PROTEIN

Structure of EDARAVONE

ACHIRAL

Protein

Protein

CYTOCHROME P450 1A2

Protein

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

Protein

CYTOCHROME P450 2C9

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1